✦ LIBER ✦
6LB The Nampt inhibitor MPC-9528 and the PARP inhibitor olaparib synergize in killing a BRCA-deficient cancer cell line
✍ Scribed by R.T. Terry-Lorenzo; T.C. Fleischer; J.W. Lockman; J.J. Boniface; J.A. Willardsen; R.O. Carlson
- Book ID
- 119602681
- Publisher
- Elsevier Science
- Year
- 2010
- Tongue
- English
- Weight
- 59 KB
- Volume
- 8
- Category
- Article
- ISSN
- 1359-6349
No coin nor oath required. For personal study only.